RIEMSER Launches AlloSorb Allograft: Sterilized Using Allowash Technology

RIEMSER, Inc., a leader in oral surgery technology, announces the launch of AlloSorb^TM, a cost-competitive allograft that provides a natural structure and framework to build healthy bone in the regeneration process.

AlloSorb^TM is a STERILE-R allograft certified by the American Association of Tissue Banks (AATB). AlloSorb utilizes the latest and most innovative sterilization and processing method, Allowash, a patented technology that minimizes the risk of disease transmission by facilitating the removal of cellular elements from musculoskeletal tissue, without degrading the tissues’ structural integrity. AlloSorb ^TM is low-dose irradiated.

Furthermore, to achieve the highest possible patient safety, the AlloSorb screening process for donors meets or exceeds FDA regulations and AATB standards.

AlloSorb^TM is available in three types of particulate – mineralized cancellous, demineralized cortical, and mineralized cortical – in .5cc, 1.0cc and 2.0cc vials. It will soon be available in block form.

"Our customers include oral surgeons, periodontists, and other implantologists who want RIEMSER to serve as a one-stop supplier for all their bone grafting needs, which is why we are pleased to add this safe, cost-competitive allograft product to our growing line,”
says Vince Ellero, Director, National Sales.

RIEMSER Inc., based in Research Triangle Park, North Carolina, has a product portfolio that also includes Cerasorb® M grafting material, EpiGuide® membrane, REVOIS® implant system, CollaGuide™ collagen membrane, and the Bacterin family of products, including OsteoSponge® Block, OsteoSponge® Filler, OsteoWrap®, and D-Block.

Source:

RIEMSER, Inc.